Fig. 5From: Exploring treatment with Ribociclib alone or in sequence/combination with Everolimus in ER+HER2−Rb wild-type and knock-down in breast cancer cell linesRib and Eveinfluenced cell cycle in Rb WT and Rb KD MCF-7 cell lines.Rb WT and Rb KD MCF-7 cell lines were treated with Rib and Eve, 10/15 μg/ml, 1:1.5ratio, alone and in combination, for 72 hBack to article page